CONMED Corporation revised earnings guidance for the full year 2024. For the period, the company's revenue is expected to be between $1.330 billion and $1.355 billion, compared to the prior guidance range of between $1.340 billion and $1.365 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
72.47 USD | -0.45% | +1.14% | -33.82% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.82% | 2.23B | |
-5.51% | 181B | |
+2.33% | 112B | |
-3.62% | 67.92B | |
+1.52% | 50.1B | |
+8.06% | 44.27B | |
+8.57% | 40.41B | |
+23.35% | 31.95B | |
+0.67% | 25.82B | |
+16.94% | 25.29B |
- Stock Market
- Equities
- CNMD Stock
- News CONMED Corporation
- CONMED Corporation Revises Earnings Guidance for the Full Year 2024